Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation

Linda Sharples; Colin Everett; Jeshika Singh; Christine Mills; Tom Spyt; Yasir Abu-omar; Simon Fynn; Benjamin Thorpe; Victoria Stoneman; Hester Goddard; Julia Fox-rushby; Samer Nashef

doi:10.3310/hta22190

Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation

Linda Sharples, Colin Everett, Jeshika Singh, Christine Mills, Tom Spyt, Yasir Abu-omar, Simon Fynn, Benjamin Thorpe, Victoria Stoneman, Hester Goddard, Julia Fox-rushby, Samer Nashef

Population Health Sciences

Research output: Contribution to journal › Article › peer-review

14 Citations (Scopus)

Original language	English
Pages (from-to)	1-132
Journal	Health Technology Assessment
Volume	22
Issue number	19
DOIs	https://doi.org/10.3310/hta22190 https://doi.org/10.3310/hta22190
Publication status	Published - 30 Apr 2018

Access to Document

https://www.journalslibrary.nihr.ac.uk/hta/hta22190

Cite this

Sharples, L., Everett, C., Singh, J., Mills, C., Spyt, T., Abu-omar, Y., Fynn, S., Thorpe, B., Stoneman, V., Goddard, H., Fox-rushby, J., & Nashef, S. (2018). Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation. Health Technology Assessment, 22(19), 1-132. https://doi.org/10.3310/hta22190, https://doi.org/10.3310/hta22190

Sharples, Linda ; Everett, Colin ; Singh, Jeshika et al. / Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation. In: Health Technology Assessment. 2018 ; Vol. 22, No. 19. pp. 1-132.

@article{835e1c90c07d42f2a83d02a84528b3e1,

title = "Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation",

author = "Linda Sharples and Colin Everett and Jeshika Singh and Christine Mills and Tom Spyt and Yasir Abu-omar and Simon Fynn and Benjamin Thorpe and Victoria Stoneman and Hester Goddard and Julia Fox-rushby and Samer Nashef",

year = "2018",

month = apr,

day = "30",

doi = "10.3310/hta22190",

language = "English",

volume = "22",

pages = "1--132",

journal = "Health Technology Assessment",

issn = "1366-5278",

publisher = "NIHR Health Technology Assessment Programme",

number = "19",

}

Sharples, L, Everett, C, Singh, J, Mills, C, Spyt, T, Abu-omar, Y, Fynn, S, Thorpe, B, Stoneman, V, Goddard, H, Fox-rushby, J & Nashef, S 2018, 'Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation', Health Technology Assessment, vol. 22, no. 19, pp. 1-132. https://doi.org/10.3310/hta22190, https://doi.org/10.3310/hta22190

Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation. / Sharples, Linda; Everett, Colin; Singh, Jeshika et al.
In: Health Technology Assessment, Vol. 22, No. 19, 30.04.2018, p. 1-132.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation

AU - Sharples, Linda

AU - Everett, Colin

AU - Singh, Jeshika

AU - Mills, Christine

AU - Spyt, Tom

AU - Abu-omar, Yasir

AU - Fynn, Simon

AU - Thorpe, Benjamin

AU - Stoneman, Victoria

AU - Goddard, Hester

AU - Fox-rushby, Julia

AU - Nashef, Samer

PY - 2018/4/30

Y1 - 2018/4/30

U2 - 10.3310/hta22190

DO - 10.3310/hta22190

M3 - Article

SN - 1366-5278

VL - 22

SP - 1

EP - 132

JO - Health Technology Assessment

JF - Health Technology Assessment

IS - 19

ER -

Sharples L, Everett C, Singh J, Mills C, Spyt T, Abu-omar Y et al. Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation. Health Technology Assessment. 2018 Apr 30;22(19):1-132. doi: 10.3310/hta22190, 10.3310/hta22190